Prenetics Global is trading 10.94% up at $24.43 as biotechnology shares rally alongside stronger U.S. equities and improved risk appetite.

  • The move appears sector-driven rather than company-specific.
  • Biotech ETF XBI is up 2.55%, while the S&P 500 and Nasdaq are also higher.
  • No fresh company-specific catalyst was identified in available coverage.